Logo image of AVNT.CA

AVANT BRANDS INC (AVNT.CA) Stock Fundamental Analysis

TSX:AVNT - Toronto Stock Exchange - CA05353D2023 - Common Stock - Currency: CAD

0.65  -0.03 (-4.41%)

Fundamental Rating

2

Taking everything into account, AVNT scores 2 out of 10 in our fundamental rating. AVNT was compared to 35 industry peers in the Pharmaceuticals industry. AVNT has a bad profitability rating. Also its financial health evaluation is rather negative. AVNT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AVNT has reported negative net income.
In the past year AVNT had a positive cash flow from operations.
In the past 5 years AVNT always reported negative net income.
In multiple years AVNT reported negative operating cash flow during the last 5 years.
AVNT.CA Yearly Net Income VS EBIT VS OCF VS FCFAVNT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

AVNT has a Return On Assets of -40.30%. This is in the lower half of the industry: AVNT underperforms 77.14% of its industry peers.
AVNT's Return On Equity of -73.31% is on the low side compared to the rest of the industry. AVNT is outperformed by 68.57% of its industry peers.
The Return On Invested Capital of AVNT (4.20%) is better than 82.86% of its industry peers.
Industry RankSector Rank
ROA -40.3%
ROE -73.31%
ROIC 4.2%
ROA(3y)-18.44%
ROA(5y)-20.49%
ROE(3y)-32.03%
ROE(5y)-31.07%
ROIC(3y)N/A
ROIC(5y)N/A
AVNT.CA Yearly ROA, ROE, ROICAVNT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

AVNT has a better Operating Margin (6.31%) than 77.14% of its industry peers.
Looking at the Gross Margin, with a value of 37.08%, AVNT is in line with its industry, outperforming 60.00% of the companies in the same industry.
AVNT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.31%
PM (TTM) N/A
GM 37.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-0.04%
AVNT.CA Yearly Profit, Operating, Gross MarginsAVNT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

AVNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AVNT has more shares outstanding
The number of shares outstanding for AVNT has been reduced compared to 5 years ago.
AVNT has a worse debt/assets ratio than last year.
AVNT.CA Yearly Shares OutstandingAVNT.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
AVNT.CA Yearly Total Debt VS Total AssetsAVNT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

AVNT has an Altman-Z score of -1.26. This is a bad value and indicates that AVNT is not financially healthy and even has some risk of bankruptcy.
AVNT has a Altman-Z score (-1.26) which is comparable to the rest of the industry.
The Debt to FCF ratio of AVNT is 26.45, which is on the high side as it means it would take AVNT, 26.45 years of fcf income to pay off all of its debts.
AVNT has a Debt to FCF ratio (26.45) which is in line with its industry peers.
AVNT has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.38, AVNT is in line with its industry, outperforming 51.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 26.45
Altman-Z -1.26
ROIC/WACC0.62
WACC6.82%
AVNT.CA Yearly LT Debt VS Equity VS FCFAVNT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

AVNT has a Current Ratio of 1.68. This is a normal value and indicates that AVNT is financially healthy and should not expect problems in meeting its short term obligations.
AVNT's Current ratio of 1.68 is in line compared to the rest of the industry. AVNT outperforms 57.14% of its industry peers.
AVNT has a Quick Ratio of 1.68. This is a bad value and indicates that AVNT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.90, AVNT is doing worse than 62.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 0.9
AVNT.CA Yearly Current Assets VS Current LiabilitesAVNT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for AVNT have decreased strongly by -57.20% in the last year.
Looking at the last year, AVNT shows a very strong growth in Revenue. The Revenue has grown by 31.94%.
Measured over the past years, AVNT shows a very strong growth in Revenue. The Revenue has been growing by 72.25% on average per year.
EPS 1Y (TTM)-57.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.9%
Revenue 1Y (TTM)31.94%
Revenue growth 3Y55.63%
Revenue growth 5Y72.25%
Sales Q2Q%2.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVNT.CA Yearly Revenue VS EstimatesAVNT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVNT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVNT.CA Price Earnings VS Forward Price EarningsAVNT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AVNT is valued cheaper than 94.29% of the companies in the same industry.
AVNT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AVNT is cheaper than 77.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.84
EV/EBITDA 4.68
AVNT.CA Per share dataAVNT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AVNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANT BRANDS INC

TSX:AVNT (8/6/2025, 7:00:00 PM)

0.65

-0.03 (-4.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-15 2025-07-15
Earnings (Next)10-13 2025-10-13
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.55%
Ins Owner ChangeN/A
Market Cap7.26M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF 11.84
P/OCF 10.6
P/B 0.25
P/tB 0.26
EV/EBITDA 4.68
EPS(TTM)-2.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.05
FCFY8.44%
OCF(TTM)0.06
OCFY9.43%
SpS3.27
BVpS2.58
TBVpS2.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.3%
ROE -73.31%
ROCE 5.83%
ROIC 4.2%
ROICexc 4.32%
ROICexgc 4.47%
OM 6.31%
PM (TTM) N/A
GM 37.08%
FCFM 1.68%
ROA(3y)-18.44%
ROA(5y)-20.49%
ROE(3y)-32.03%
ROE(5y)-31.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-0.04%
F-Score3
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 26.45
Debt/EBITDA 2.26
Cap/Depr 2.92%
Cap/Sales 0.2%
Interest Coverage 250
Cash Conversion 14.36%
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 0.9
Altman-Z -1.26
F-Score3
WACC6.82%
ROIC/WACC0.62
Cap/Depr(3y)30.6%
Cap/Depr(5y)37.88%
Cap/Sales(3y)6.99%
Cap/Sales(5y)7.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.94%
Revenue growth 3Y55.63%
Revenue growth 5Y72.25%
Sales Q2Q%2.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y199.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y186.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.7%
OCF growth 3YN/A
OCF growth 5YN/A